Alexandra Morton
Women's Health · Tulsa, OKNPI 1609404946
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 36.8% of the total. Reporting peaked in 2021 at $1,099 and has fallen 98.4% since, to $17 in 2024.
Across 178 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$980
- Mayne Pharma Commercial LLC$258
- Astellas Pharma US Inc$211
- Therapeuticsmd, Inc.$201
- Currax Pharmaceuticals LLC$140
- Pfizer$109
- plus $768 from 21 others
What the payments were for
- Food & beverage$2,56796%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $980 |
| Mayne Pharma Commercial LLC | 25 | $258 |
| Astellas Pharma US Inc | 6 | $211 |
| Therapeuticsmd, Inc. | 14 | $201 |
| Currax Pharmaceuticals LLC | 10 | $140 |
| Pfizer | 6 | $109 |
| Myovant Sciences Inc. | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $83 |
| Agile Therapeutics, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $51 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Scynexis, Inc. | 2 | $34 |
| Bayer | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Organon | 2 | $28 |
| Ardelyx, Inc. | 2 | $28 |
| Sumitomo Pharma America, Inc. | 2 | $26 |
| Davol Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Minerva Surgical, Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Millicent US Inc | 1 | $14 |
How this compares
$2,667 in reported general payments places this provider in the 85th percentile of 62 women's health providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $1,953 |
| Alendronate Sodium | 14 | $132 |
Paid to pharmacies, not to this prescriber.
Other women's health in Tulsa
- April ZumwaltTulsa$4K
- Kerri VandiverTulsa$3K
- Melanie MeadTulsa$3K
- Melissa WilsonTulsa$2K
- Julie StylesTulsa$915
- Kelley ScottTulsa$717
- Leslie KingTulsa$360
- Sherri FisherTulsa$133
- Kelly StemmTulsa$63
- Delana GreggTulsa$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.